Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0DYQ stock hub

LON/0DYQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0DYQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

130.5M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0DYQ

In the news

Latest news · LON/0DYQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E5.3

P25 12.9P50 16.9P75 23.5

Trailing P/E15.9

P25 15.9P50 22.9P75 35.8

ROE2.9

P25 -54.2P50 2.1P75 13.7

ROIC6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0DYQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

EUR

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	6,605
Enterprise value	EUR 345.8M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	FR0000053506
Last refreshed	2026-05-10
Market cap	EUR 130.5M
Price	EUR 10.86
Price currency	EUR
Rev Per Employee	87,126.43x
Sector	Healthcare
Sic	7374
Symbol	lon/0DYQ
Website	https://www.cegedim.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.28%
EV Earnings	42.18x
EV/EBIT	11.46x
EV/EBITDA	5.56x
EV/FCF	3.1x
EV/Sales	0.62x
FCF yield	85.62%
Forward P/E	5.27x
P/B ratio	0.51x
P/E ratio	15.91x
P/S ratio	0.23x
PE Ratio10 Y	38.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.65%
EBITDA Margin	8.83%
FCF margin	19.72%
Gross margin	41.86%
Gross Profit	EUR 237.1M
Gross Profit Growth	-1.17%
Gross Profit Growth Q	-2.24%
Gross Profit Growth3 Y	0.88%
Gross Profit Growth5 Y	2.26%
Net Income	EUR 8.2M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	67.05%
Net Income Growth5 Y	-0.64%
Pretax Margin	1.48%
Profit Margin	1.45%
Profit Per Employee	EUR 1,261
Profitable Years	1
ROA	2.3
Roa5y	2.25
ROCE	5.82
ROE	2.89
Roe5y	2.29
ROIC	6.05
Roic5y	3.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.42%
Cagr1y	-6.38%
Cagr3y	-17.72%
Cagr5y	-15.1%
Div CAGR10	0%
Div CAGR5	0%
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	66.55
EPS Growth5 Y	-0.8
FCF Growth	81.52%
FCF Growth Q	30.54%
FCF Growth3 Y	24.39%
FCF Growth5 Y	7.38%
OCF Growth	49.43%
OCF Growth Q	20.02%
OCF Growth10 Y	3.26%
OCF Growth3 Y	17.99%
OCF Growth5 Y	6.52%
Revenue Growth	-0.81x
Revenue Growth Q	-2.63x
Revenue Growth Years	0x
Revenue Growth3 Y	0.79x
Revenue Growth5 Y	1.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.65
Assets	EUR 873.4M
Cash	EUR 80.6M
Current Assets	EUR 318.1M
Current Liabilities	EUR 321.5M
Debt	EUR 283.2M
Debt EBITDA	EUR 4.4
Debt Equity	EUR 1.11
Debt FCF	EUR 2.53
Equity	EUR 254.5M
Interest Coverage	1.82
Liabilities	EUR 618.9M
Long Term Assets	EUR 555.4M
Long Term Liabilities	EUR 297.4M
Net Cash	EUR -202.6M
Net Cash By Market Cap	EUR -155
Net Debt EBITDA	EUR 4.05
Net Debt Equity	EUR 0.8
Net Debt FCF	EUR 1.81
Tangible Book Value	EUR -124.5M
Tangible Book Value Per Share	EUR -9.07
WACC	6.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Inventory Turnover	111.3
Net Working Capital	EUR -63.8M
Quick ratio	0.92
Working Capital	EUR -3.5M
Working Capital Turnover	EUR -105

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.34%
Dividend per share	EUR 0
Last Dividend	EUR 0.43

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-53.74%
1Y total return	-6.38%
200-day SMA	11.7
3Y total return	-44.31%
50-day SMA	12.22
50-day SMA vs 200-day SMA	50over200
5Y total return	-55.88%
All Time High	42.69
All Time High Change	-74.56%
All Time High Date	2015-07-20
All Time Low	8.6
All Time Low Change	26.28%
All Time Low Date	2026-03-23
ATR	0.54
Beta	0.62
Ch YTD	-18.96
High	10.86
High52	14.8
High52 Date	2026-01-05
High52ch	-26.62%
Low	10.86
Low52	8.6
Low52 Date	2026-03-23
Low52ch	26.28%
Ma50ch	-11.15%
Price vs 200-day SMA	-7.15%
RSI	42.88
RSI Monthly	40.03
RSI Weekly	47.16
Sharpe ratio	-0.46x
Sortino ratio	-0.55
Total Return	-0.34%
Tr YTD	-18.96
Tr1m	-14.15%
Tr1w	0.18%
Tr3m	-8.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 32M
Operating Income Growth	-17.52
Operating Income Growth Q	-27.34
Operating Income Growth3 Y	8.23
Operating Income Growth5 Y	5.56
Operating margin	5.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,238,947%
Net Borrowing	-20,990,858.9
Shares Insiders	0.4%
Shares Institutions	16.67%
Shares Qo Q	0.17%
Shares Yo Y	0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 111.7M
Average Volume	12.85x
Bv Per Share	17.45
CAPEX	EUR -21.1M
Ch10y	-54.76
Ch1m	-14.15
Ch1w	0.18
Ch1y	-6.38
Ch3m	-8.74
Ch3y	-44.31
Ch5y	-56.85
Ch6m	-7.57
Change	0.18%
Change From Open	0
Close	10.84
Days Gap	0.18
Depreciation Amortization	17,863,769.4
Earnings Date	2026-09-24
EBIT	EUR 32M
EBITDA	EUR 50M
EPS	EUR 0.6
F Score	6
FCF	EUR 111.7M
FCF EV Yield	32.3x
Financing CF	-35,759,438
Fiscal Year End	December
Founded	1,969
Goodwill	202,460,666.5
Graham Number	18.03673
Graham Upside	66.08
Income Tax	EUR 1.1M
Investing CF	-59,511,535
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Lynch Fair Value	EUR 3.41
Lynch Upside	-68.58
Ma150	11.42
Ma150ch	-4.9%
Ma20	11.37
Ma20ch	-4.52%
Net CF	37,306,155
Next Earnings Date	2026-09-24
Open	10.86
P FCF Ratio	1.17
P OCF Ratio	0.98
Ppne	137,307,344.8
Price Date	2026-05-08
Price EBITDA	EUR 2.61
Relative Volume	72.17x
Revenue	566,321,806x
Tax By Revenue	0.2x
Tax Rate	13.52%
Tr6m	-7.57%
Z Score	0.91

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0DYQ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0DYQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0DYQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.7%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

LON/0DYQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.9

Neutral momentum band

Price vs 200-day MA

-7.1%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

-0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0DYQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0DYQ stock rating?

lon/0DYQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0DYQ analysis?

The full report lives at /stocks/lon/0DYQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0DYQ?

The latest report frames lon/0DYQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0DYQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.